Evidence map›Paper›PMID 39692814›Full record

ReviewDiscover oncology2024

Research progress on the anti-tumor effects of euphorbia humifusa.

Xiaoxue Zhao, Chengcheng Zhang, Xinle Qian, Jia Zhang, Guoying Wang, Zhongqi Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. 3,3'-Di-O-methylellagic Acid Isolated fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoxue Zhao *Department of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Chengcheng Zhang *Department of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xinle Qian *Department of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Jia ZhangProvincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Guoying WangDepartment of Critical Care Medicine, The Second People's Hospital of Dongying, Dongying, Shandong, China. icuwangguoying@163.com.
Zhongqi WangDepartment of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. aledx@sina.com.

Funding

National Thirteenth Five-Year Science and Technology Major Special Project for New Drug Innovation and Development 2017ZX09304001Science and Technology Commission of Shanghai Municipality No.20Y21902300Shanghai Hospital Development Center SHDC2020CR4050Shanghai Municipal Health Commission 022YQ028Shanghai Municipal Health Commission shslczdzk03701Shanghai "Science and Technology Innovation Action Plan" Medical Innovation Research Project 21MC1930500
6 · The paper itself

Abstract

EH (Euphorbia Humifusa) is commonly known as ground spurge, contains various compounds such as flavonoids, triterpenes, coumarins, sterols, tannins, and phenolic acids. It exerts a wide spectrum of properties including anti-bacterial, anti-inflammatory, Antioxidant, anti-viral, hypoglycemic, and anti-tumor. In this article, we focus on the antitumor effects of EH and its active constituents, providing evidence for further research on this medicinal herb.

Indexed as

AntitumorChemical constituentsEuphorbia humifusaePharmacological effects

Identifiers

PMID39692814
PMCPMC11655944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.